PediatricsInternal MedicineNeurology

myasthenia gravis

Q: What is the primary target of autoantibodies in myasthenia gravis?

Myasthenia gravis is an autoimmune disorder where antibodies form against nicotinic acetylcholine (AChR) postsynaptic receptors at the neuromuscular junction of skeletal muscles. This is the defining pathophysiology of the disease.

Q: Which antibody type is most commonly found in myasthenia gravis and is associated with thymoma?

Anti-AChR antibodies are the most common type found in MG and cause complement-mediated postsynaptic damage. They are often thymoma-related according to the summary.

Q: What is the hallmark clinical feature of myasthenia gravis?

The hallmark of MG is fatigable weakness that characteristically worsens toward the end of the day and improves with rest. This distinguishes it from other neuromuscular conditions.

Q: What happens to endplate potential (EPP) amplitude in myasthenia gravis?

Due to autoantibody effects including AChR cross-linking, receptor internalization, complement activation causing membrane damage, and decreased Na+ channel density, the EPP amplitude decreases in MG.

Q: Which imaging study should be performed in ALL patients with suspected myasthenia gravis?

CT Chest should be performed in ALL patients with MG to rule out thymoma, as stated in Step 4 of the diagnostic approach. Thymoma is associated with MG and requires specific management.

Myasthenia gravis is an autoimmune disorder in which antibodies target nicotinic acetylcholine receptors at the neuromuscular junction, leading to complement-mediated damage and reduced endplate potential amplitude that manifests as fatigable weakness worsening throughout the day and improving with rest. The condition holds particular clinical significance because it can progress to life-threatening myasthenic crisis requiring ICU-level care, has a strong association with thymic abnormalities necessitating chest imaging in all patients, and requires careful differentiation from mimics like Lambert-Eaton syndrome and botulism. Medical students must recognize the characteristic pattern of ocular, bulbar, and proximal limb involvement, understand the stepwise diagnostic approach from serology to electrodiagnostics, and appreciate that management spans symptomatic treatment with pyridostigmine through immunotherapy and thymectomy, with awareness of drugs that can precipitate crisis.

Free forever

The summary, the quiz, and the download stay accessible without forcing a sign-in flow. Donations only support the mission.

myasthenia gravis one-page medical summary

Right-click or long-press to save the image directly.

Quiz mode

Test your knowledge

Answer the visible questions first, then score yourself before revealing more.

1. What is the primary target of autoantibodies in myasthenia gravis?

2. Which antibody type is most commonly found in myasthenia gravis and is associated with thymoma?

3. What is the hallmark clinical feature of myasthenia gravis?

4. What happens to endplate potential (EPP) amplitude in myasthenia gravis?

5. Which imaging study should be performed in ALL patients with suspected myasthenia gravis?

Answer all 5 visible questions to submit.

myasthenia gravis

Test your knowledge

More in Pediatrics

neural tube defects

dehydration in paediatrics

juvenile idiopathic arthritis / juvenile rheumatoid arthritis